-
|
BOLD
|
Boundless Bio, Inc. Common Stock
|
XNAS |
CS
|
$27.53M |
-
|
BCTX
|
Briacell Therapeutics Corp. Common Shares
|
XNAS |
CS
|
$21.31M |
-
|
BCTXW
|
BriaCell Therapeutics Corp. Warrant
|
XNAS |
WARRANT
|
- |
-
|
BCTXZ
|
BriaCell Therapeutics Corp. Warrant
|
XNAS |
WARRANT
|
- |
-
|
BBOT
|
BridgeBio Oncology Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$962.24M |
-
|
BBIO
|
BridgeBio Pharma, Inc. Common Stock
|
XNAS |
CS
|
$11.91B |
-
|
BMY
|
Bristol-Myers Squibb Co.
|
XNYS |
CS
|
$95.05B |
|
-
|
CELGR
|
Bristol-Myers Squibb Company Contingent Value Rights
|
XNYS |
RIGHT
|
- |
-
|
BFRG
|
Bullfrog AI Holdings, Inc. Common Stock
|
XNAS |
CS
|
$11.44M |
-
|
BFRGW
|
Bullfrog AI Holdings, Inc. Warrants
|
XNAS |
WARRANT
|
- |
-
|
CVKD
|
Cadrenal Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$24.86M |
|
-
|
CPSR
|
Calamos S&P 500 Structured Alt Protection ETF - March
|
ARCX |
ETF
|
- |
-
|
CALC
|
CalciMedica, Inc. Common Stock
|
XNAS |
CS
|
$42.48M |
-
|
CAMP
|
CAMP4 Therapeutics Corporation Common Stock
|
XNAS |
CS
|
$85.68M |
-
|
CAPR
|
Capricor Therapeutics Inc
|
XNAS |
CS
|
$271.10M |
-
|
RNAC
|
Cartesian Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$204.64M |
-
|
SAVA
|
Cassava Sciences, Inc.
|
XNAS |
CS
|
$142.99M |
-
|
CPRX
|
Catalyst Pharmaceutical Inc.
|
XNAS |
CS
|
$2.63B |
-
|
CDT
|
CDT Equity Inc. Common Stock
|
XNAS |
CS
|
$3.39M |
-
|
CDTTW
|
CDT Equity Inc. Warrant
|
XNAS |
WARRANT
|
- |
-
|
CLRB
|
Cellectar Biosciences INC NEW
|
XNAS |
CS
|
$10.82M |
-
|
CELU
|
Celularity Inc. Class A Common Stock
|
XNAS |
CS
|
$47.51M |
-
|
CELUW
|
Celularity Inc. Warrant
|
XNAS |
WARRANT
|
- |
-
|
CNTA
|
Centessa Pharmaceuticals plc American Depositary Shares
|
XNAS |
ADRC
|
$2.97B |
-
|
CRVO
|
CervoMed Inc. Common Stock
|
XNAS |
CS
|
$64.03M |
-
|
CMMB
|
Chemomab Therapeutics Ltd. American Depositary Share
|
XNAS |
ADRC
|
$13.70M |
-
|
CPHI
|
China Pharma Holdings, Inc.
|
XASE |
CS
|
$5.06M |
|
-
|
CING
|
Cingulate Inc. Common Stock
|
XNAS |
CS
|
$20.91M |
|
-
|
CINGW
|
Cingulate Inc. Warrants
|
XNAS |
WARRANT
|
- |
|
-
|
CTOR
|
Citius Oncology, Inc. Common Stock
|
XNAS |
CS
|
$116.92M |
-
|
CTXR
|
Citius Pharmaceuticals Inc. Common
|
XNAS |
CS
|
$23.09M |
-
|
CLSD
|
Clearside Biomedical, Inc. Common Stock
|
XNAS |
CS
|
$19.47M |
-
|
CLNN
|
Clene Inc. Common Stock
|
XNAS |
CS
|
$98.53M |
-
|
CLNNW
|
Clene Inc. Warrant
|
XNAS |
WARRANT
|
- |
-
|
CLYM
|
Climb Bio, Inc. Common Stock
|
XNAS |
CS
|
$124.01M |
-
|
CNSP
|
CNS Pharmaceuticals, Inc. Common Stock
|
XNAS |
CS
|
$3.77M |
-
|
COCP
|
Cocrystal Pharma, Inc. Common Stock
|
XNAS |
CS
|
$15.16M |
-
|
COGT
|
Cogent Biosciences, Inc. Common Stock
|
XNAS |
CS
|
$2.07B |
-
|
COLL
|
Collegium Pharmaceutical, Inc. Common Stock
|
XNAS |
CS
|
$1.34B |
-
|
CMPS
|
COMPASS Pathways Plc American Depository Shares
|
XNAS |
ADRC
|
$523.29M |
-
|
CNTB
|
Connect Biopharma Holdings Limited Ordinary Shares
|
XNAS |
CS
|
$86.38M |
-
|
CNTX
|
Context Therapeutics Inc. Common Stock
|
XNAS |
CS
|
$102.90M |
-
|
CTNM
|
Contineum Therapeutics, Inc. Class A Common Stock
|
XNAS |
CS
|
$318.82M |
-
|
CRBP
|
Corbus Pharmaceuticals Holdings, Inc.
|
XNAS |
CS
|
$178.83M |
-
|
CORT
|
Corcept Therapeutics Inc.
|
XNAS |
CS
|
$7.75B |
-
|
CRMD
|
CorMedix Inc.
|
XNAS |
CS
|
$843.04M |
-
|
CRVS
|
Corvus Pharmaceuticals, Inc.
|
XNAS |
CS
|
$567.58M |
-
|
COYA
|
Coya Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$120.52M |
|
-
|
CBIO
|
Crescent Biopharma, Inc. Common Stock
|
XNAS |
CS
|
$220.36M |
-
|
CRNX
|
Crinetics Pharmaceuticals, Inc.
|
XNAS |
CS
|
$3.80B |
-
|
CYRX
|
CryoPort, Inc. Common Stock
|
XNAS |
CS
|
$419.58M |
-
|
CUE
|
Cue Biopharma, Inc.
|
XNAS |
CS
|
$53.88M |
-
|
CPIX
|
Cumberland Pharmaceuticals Inc
|
XNAS |
CS
|
$31.86M |
|
-
|
CURX
|
Curanex Pharmaceuticals Inc Common Stock
|
XNAS |
CS
|
$17.57M |
-
|
CYCN
|
Cyclerion Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$5.20M |
-
|
CYTK
|
Cytokinetics Inc.
|
XNAS |
CS
|
$7.36B |
-
|
CTMX
|
CytomX Therapeutics, Inc.
|
XNAS |
CS
|
$596.98M |
-
|
DARE
|
Dare Bioscience, Inc. Common Stock
|
XNAS |
CS
|
$24.67M |
-
|
DAWN
|
Day One Biopharmaceuticals, Inc. Common Stock
|
XNAS |
CS
|
$999.03M |
-
|
DRMA
|
Dermata Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$2.07M |
-
|
DRMAW
|
Dermata Therapeutics, Inc. Warrant
|
XNAS |
WARRANT
|
- |
-
|
DSGN
|
Design Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$430.65M |
-
|
DMAC
|
DiaMedica Therapeutics Inc. Common Stock
|
XNAS |
CS
|
$306.00M |
-
|
DNTH
|
Dianthus Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$1.56B |
-
|
IRON
|
Disc Medicine, Inc. Common Stock
|
XNAS |
CS
|
$3.17B |
-
|
DWTX
|
Dogwood Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$12.06M |
-
|
DVAX
|
Dynavax Technologies Corporation
|
XNAS |
CS
|
$1.27B |
|
-
|
DYN
|
Dyne Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$2.62B |
-
|
EDSA
|
Edesa Biotech, Inc. Common Shares
|
XNAS |
CS
|
$12.55M |
-
|
EWTX
|
Edgewise Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$1.82B |
-
|
ELAN
|
Elanco Animal Health Incorporated Common Stock
|
XNYS |
CS
|
$10.68B |
-
|
ELDN
|
Eledon Pharmaceuticals, Inc. Common Stock
|
XNAS |
CS
|
$123.36M |
-
|
LLY
|
Eli Lilly & Co.
|
XNYS |
CS
|
$827.33B |
-
|
ELTX
|
Elicio Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$144.92M |
-
|
EBS
|
Emergent Biosolutions, Inc.
|
XNYS |
CS
|
$533.60M |
-
|
ENTA
|
Enanta Pharmaceuticals, Inc
|
XNAS |
CS
|
$317.09M |
-
|
ELVN
|
Enliven Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$1.04B |
-
|
ENSC
|
Ensysce Biosciences, Inc. Common Stock
|
XNAS |
CS
|
$6.11M |
-
|
ENTO
|
Entero Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$8.28M |
|
-
|
TRDA
|
Entrada Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$264.09M |
-
|
ENVB
|
Enveric Biosciences, Inc. Common Stock
|
XNAS |
CS
|
$3.17M |
|
-
|
EQ
|
Equillium, Inc. Common Stock
|
XNAS |
CS
|
$65.45M |
-
|
ERAS
|
Erasca, Inc. Common Stock
|
XNAS |
CS
|
$643.93M |
-
|
ERNA
|
Ernexa Therapeutics Inc. Common Stock
|
XNAS |
CS
|
$13.42M |
-
|
ESPR
|
Esperion Therapeutics, Inc.
|
XNAS |
CS
|
$630.60M |
-
|
ETHZ
|
ETHZilla Corporation Common Stock
|
XNAS |
CS
|
$286.57M |
-
|
ETON
|
Eton Pharmaceutcials, Inc. Common Stock
|
XNAS |
CS
|
$453.22M |
-
|
EVOK
|
Evoke Pharma, Inc.
|
XNAS |
CS
|
$16.66M |
-
|
EOLS
|
Evolus, Inc. Common Stock
|
XNAS |
CS
|
$425.22M |
|
-
|
XCUR
|
Exicure, Inc. Common Stock
|
XNAS |
CS
|
$25.02M |
-
|
FBLG
|
FibroBiologics, Inc. Common Stock
|
XNAS |
CS
|
$18.13M |
-
|
FGEN
|
FibroGen, Inc
|
XNAS |
CS
|
$44.60M |
-
|
FLGC
|
Flora Growth Corp. Common Stock
|
XNAS |
CS
|
$5.71M |
-
|
FHTX
|
Foghorn Therapeutics Inc. Common Stock
|
XNAS |
CS
|
$246.56M |
-
|
FBRX
|
Forte Biosciences, Inc. Common Stock
|
XNAS |
CS
|
$150.19M |
-
|
FBIO
|
Fortress Biotech, Inc.
|
XNAS |
CS
|
$77.66M |
-
|
FBIOP
|
Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
|
XNAS |
PFD
|
- |
-
|
FULC
|
Fulcrum Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$412.92M |
-
|
GANX
|
Gain Therapeutics, Inc. Common Stock
|
XNAS |
CS
|
$70.46M |
-
|
GALT
|
Galectin Therapeutics Inc.
|
XNAS |
CS
|
$335.29M |